Improved survival with elevated BMI following immune checkpoint inhibition across various solid tumor cancer types

• DOI: 10.1002/cncr.35799
• Publication Date: 2025-03-12T07:07:53Z
• Authors: Eric V. Mastrolon...; Pablo Llerena; Emma De Ravin; Kathryn Nunes; Praneet C. Kaki; Kelly M. Bridgham; Dev R. Amin; Daniel J. Campbell; Ramez Philips; Scott H. Koeneman; David M. Cognetti; Adam J. Luginbuhl; Nicole L. Simone; Jennifer M. Johnson; Joseph M. Curry

Studies investigating the clinical benefits of obesity across various cancer types are limited. This big data study demonstrates that obesity is associated with improved overall survival up to 5 years after treatment with immune checkpoint inhibition across various solid tumor malignancies.